Determination of Allopurinol and Oxypurinol in Human Plasma and Urine by Liquid Chromatography-Tandem Mass Spectrometry

Xia Liu,Xiao-Jia Ni,De-Wei Shang,Ming Zhang,Jin-Qing Hu,Chang Qiu,Fu-Tian Luo,Yu-Guan Wen

DOI: https://doi.org/10.1016/j.jchromb.2013.09.028

IF: 3.318

2013-01-01

Journal of Chromatography B

Abstract:Allopurinol is used widely for the treatment of gout, but its pharmacokinetics is complex and some patients show hypersensitivity, necessitating careful monitoring and improved detection methods. In this study, a sensitive and reliable liquid chromatography-tandem mass spectrometry method was developed to determine the concentrations of allopurinol and its active metabolite oxypurinol in human plasma and urine using 2,6-dichloropurine as the internal standard (IS). Analytes and the IS were extracted from 0.5 ml aliquots of plasma or urine using ethyl acetate and separated on an Agilent Eclipse Plus C-18 column using methanol and ammonium formate-formic acid buffer containing 5 mM ammonium formate and 0.1% formic acid (95:5, v/v) as the mobile phase (A) for allopurinol or methanol plus 5 mM ammonium formate aqueous solution (95:5, v/v) as the mobile phase (B) for oxypurinol. Allopurinol was detected in positive ion mode and the analysis time was about 7 min. The calibration curve was linear from 0.05 to 5 mu g/mL allopurinol in plasma and 0.5-30 mu g/mL in urine. The lower limit of quantification (LLOQ) was 0.05 mu g/mL in plasma and 0.5 mu g/mL in urine. The intra- and inter-day precision and relative errors of quality control (QC) samples were <= 11.1% for plasma and <= 8.7% for urine. Oxypurinol was detected in negative mode with an analysis time of about 4 min. The calibration curve was linear from 0.05 to 5 mu g/mL in plasma (LLOQ, 0.05 mu g/mL) and from 1 to 50 mu g/mL in urine (LLOQ 1 mu g/mL). The intra- and inter-day precision and relative errors were <= 7.0% for plasma and <= 9.6% for urine. This method was then successfully applied to investigate the pharmacokinetics of allopurinol and oxypurinol in humans. (C) 2013 Elsevier B.V. All rights reserved.